SCHEMBL530796

SCHEMBL530796

[CH2]c1[c]cccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9189179 0.69
SCHEMBL2922010 0.69
SCHEMBL115447 0.67 CYP3A4 (0.33)
SCHEMBL185933 0.65
SCHEMBL6709739 0.63
SCHEMBL7763042 0.63
SCHEMBL1375064 0.63
SCHEMBL93904 0.63
SCHEMBL5469060 0.63
SCHEMBL11786338 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 277 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109671852-B Organic light emitting device and flat panel display device including the same 三星显示有限公司 2023-09-01 CN claimed
CN-115745963-A Protein degradation compound based on NAMPT target protein and application thereof 标新生物医药科技(上海)有限公司 2023-03-07 CN claimed
CN-115611902-A Protein degradation compound designed based on Bruton's tyrosine kinase ligand and application thereof 标新生物医药科技(上海)有限公司 2023-01-17 CN claimed
CN-114685513-A Compound with triazine derivative as core and application thereof 江苏三月科技股份有限公司 2022-07-01 CN claimed
CN-114075180-A Immunomodulatory compounds and their anti-tumor applications 上海科技大学 2022-02-22 CN claimed
CN-113582980-A Compound based on heterocyclic ring and glutarimide framework and application thereof 上海科技大学 2021-11-02 CN claimed
EP-2855494-B1 IRON CATALYSTS WITH UNSYMMETRICAL PNN'P LIGANDS GOVERNING COUNCIL UNIV TORONTO (CA) 2020-12-23 EP claimed
EP-3126517-B1 MODIFIED CYTOSINE POLYNUCLEOTIDE OLIGOMERS AND METHODS CEPHEID (US) 2019-10-23 EP claimed
EP-3505192-A1 RADIOLABELED PROSTATE SPECIFIC MEMBRANE ANTIGEN INHIBITORS Molecular Insight Pharmaceuticals, Inc. (US) 2019-07-03 EP claimed
EP-3126372-B1 MODIFIED THYMINE POLYNUCLEOTIDE OLIGOMERS AND METHODS CEPHEID (US) 2019-02-06 EP claimed
CN-1984679-A Methods for preparing immunogenic conjugates US GOVERNMENT (US) 2007-06-20 CN claimed
EP-1765394-A1 METHODS FOR PREPARING IMMUNOGENIC CONJUGATES THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH &amp; HUMAN SERVICES (US) 2007-03-28 EP claimed
WO-2005117965-A1 METHODS FOR PREPARING IMMUNOGENIC CONJUGATES THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2005-12-15 WO claimed
US-20050271675-A1 Methods for preparing immunogenic conjugates THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF 2005-12-08 US claimed
CN-1203788-A Therapeutic agent for rheumatic disease comprising nonsteroidal anti-inflammatory drug and phenylpropionic acid derivative SANTEN PHARMACEUTICAL CO LTD (JP) 1999-01-06 CN claimed
EP-0688444-B1 POLYMERS EXHIBITING NONLINEAR OPTICAL PROPERTIES ALLIED SIGNAL INC (US) 1998-05-13 EP claimed
US-5670603-A POLYESTER,-ETHERS, AMIDES, URETHANES,-EPOXIDES,-IMIDES, AND CARBONATES BASED ON MONOMERS OF 9,9-BIS/SUBSTITUTED PHENYLFLUORENE COMPOUNDS HAVING ELECTRON WITHDRAWING AND DONATING GROUPS; HEAT RESISTANCE; THIN FILMS ALLIEDSIGNAL INC. (US) 1997-09-23 US claimed
EP-0688444-A1 POLYMERS EXHIBITING NONLINEAR OPTICAL PROPERTIES AlliedSignal Inc. (US) 1995-12-27 EP claimed
WO-1994020881-A1 POLYMERS EXHIBITING NONLINEAR OPTICAL PROPERTIES ALLIEDSIGNAL INC. (US) 1994-09-15 WO claimed
US-3950396-A LUBRICANTS, COSMETICS, PAINTS, INKS, FIBERS KAO SOAP CO., LTD. (JA) 1976-04-13 US claimed